Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Theodoros Karantanos, Ioannis Politikos & Vassiliki A Boussiotis. (2017) Advances in the pathophysiology and treatment of relapsed/refractory Hodgkin’s lymphoma with an emphasis on targeted therapies and transplantation strategies. Blood and Lymphatic Cancer: Targets and Therapy 7, pages 37-52.
Read now
Read now
Marta Celegato, Cinzia Borghese, Naike Casagrande, Antonino Carbone, Alfonso Colombatti & Donatella Aldinucci. (2014) Bortezomib down-modulates the survival factor interferon regulatory factor 4 in Hodgkin lymphoma cell lines and decreases the protective activity of Hodgkin lymphoma-associated fibroblasts. Leukemia & Lymphoma 55:1, pages 149-159.
Read now
Read now
Articles from other publishers (36)
Sylwia Popek-Marciniec, Wojciech Styk, Magdalena Wojcierowska-Litwin, Aneta Szudy-Szczyrek, Paul Dudek, Grazyna Swiderska-Kolacz, Joanna Czerwik-Marcinkowska & Szymon Zmorzynski. (2023) The Relationship of CCL5 and CCR1 Variants with Response Rate and Survival Taking into Account Thalidomide/Bortezomib Treatment in Patients with Multiple Myeloma. Journal of Clinical Medicine 12:6, pages 2384.
Crossref
Crossref
Maura Rossi, Francesco Alviano, Barie Myrtaj, Silvia Zia, Simona Righi, Valeria Pizzuti, Francesca Paris, Barbara Roda, Andrea Zattoni, Laura Bonsi, Elena Sabattini & Claudio Agostinelli. (2023) The Medium Obtained from the Culture of Hodgkin Lymphoma Cells Affects the Biophysical Characteristics of a Fibroblast Cell Model. Bioengineering 10:2, pages 197.
Crossref
Crossref
Maria Beatriz Álvarez Flores, María Sopeña Corvinos, María Medrano Élez, Beatriz Soto del Pecho, Luz Conejo Sánchez, Javier García de la Fe, Raquel Guillén Santos & Fernado Cava Valenciano. (2023) A new approach to the study of Hodgkin lymphoma by flow cytometry. Pathology 55:1, pages 86-93.
Crossref
Crossref
Manzoor Ahmad Mir, Aamina Manzoor & Nusrat Jan. 2023. Cytokine and Chemokine Networks in Cancer. Cytokine and Chemokine Networks in Cancer
219
240
.
Pengbo Zhang & Huang Zhu. (2022) Cytokines in Thyroid-Associated Ophthalmopathy. Journal of Immunology Research 2022, pages 1-12.
Crossref
Crossref
Daniel J. García-Domínguez, Lourdes Hontecillas-Prieto, Natalia Palazón-Carrión, Carlos Jiménez-Cortegana, Víctor Sánchez-Margalet & Luis de la Cruz-Merino. (2022) Tumor Immune Microenvironment in Lymphoma: Focus on Epigenetics. Cancers 14:6, pages 1469.
Crossref
Crossref
Giuseppe Ingravallo, Roberto Tamma, Giuseppina Opinto, Tiziana Annese, Francesco Gaudio, Giorgina Specchia, Tommasina Perrone, Pellegrino Musto, Gerardo Cazzato, Emilio Bellitti, Saverio Capodiferro, Eugenio Maiorano & Domenico Ribatti. (2022) The Effect of the Tumor Microenvironment on Lymphoid Neoplasms Derived from B Cells. Diagnostics 12:3, pages 573.
Crossref
Crossref
Xiaowei Wang, Wenjia Su, Dabei Tang, Jing Jing, Jing Xiong, Yuwei Deng, Huili Liu, Wenjie Ma, Zhaoliang Liu & Qingyuan Zhang. (2021) An Immune-Related Gene Prognostic Index for Triple-Negative Breast Cancer Integrates Multiple Aspects of Tumor-Immune Microenvironment. Cancers 13:21, pages 5342.
Crossref
Crossref
Giuseppina Opinto, Claudio Agostinelli, Sabino Ciavarella, Attilio Guarini, Eugenio Maiorano & Giuseppe Ingravallo. (2021) Hodgkin Lymphoma: A Special Microenvironment. Journal of Clinical Medicine 10:20, pages 4665.
Crossref
Crossref
Jose-Tomas Navarro, José Moltó, Gustavo Tapia & Josep-Maria Ribera. (2021) Hodgkin Lymphoma in People Living with HIV. Cancers 13:17, pages 4366.
Crossref
Crossref
Clifford M. Csizmar & Stephen M. Ansell. (2021) Engaging the Innate and Adaptive Antitumor Immune Response in Lymphoma. International Journal of Molecular Sciences 22:7, pages 3302.
Crossref
Crossref
Donatella Aldinucci, Cinzia Borghese & Naike Casagrande. (2020) The CCL5/CCR5 Axis in Cancer Progression. Cancers 12:7, pages 1765.
Crossref
Crossref
Katrin Bankov, Claudia Döring, Adam Ustaszewski, Maciej Giefing, Marco Herling, Chiara Cencioni, Francesco Spallotta, Carlo Gaetano, Ralf Küppers, Martin-Leo Hansmann & Sylvia Hartmann. (2019) Fibroblasts in Nodular Sclerosing Classical Hodgkin Lymphoma Are Defined by a Specific Phenotype and Protect Tumor Cells from Brentuximab-Vedotin Induced Injury. Cancers 11:11, pages 1687.
Crossref
Crossref
Lovorka Grgurević, Ruđer Novak, Vladimir Trkulja, Lejla Ferhatović Hamzić, Stela Hrkač, Simeon Grazio & Marija Santini. (2019) Elevated plasma RANTES in fibrodysplasia ossificans progressiva – A novel therapeutic target?. Medical Hypotheses 131, pages 109313.
Crossref
Crossref
Donatella Aldinucci, Cinzia Borghese & Naike Casagrande. (2019) Formation of the Immunosuppressive Microenvironment of Classic Hodgkin Lymphoma and Therapeutic Approaches to Counter It. International Journal of Molecular Sciences 20:10, pages 2416.
Crossref
Crossref
Diego De Goycoechea, Gregoire Stalder, Filipe Martins & Michel A. Duchosal. (2019) Immune Checkpoint Inhibition in Classical Hodgkin Lymphoma: From Early Achievements towards New Perspectives. Journal of Oncology 2019, pages 1-16.
Crossref
Crossref
Nicholas Meti, Khashayar Esfahani & Nathalie Johnson. (2018) The Role of Immune Checkpoint Inhibitors in Classical Hodgkin Lymphoma. Cancers 10:6, pages 204.
Crossref
Crossref
Donatella Aldinucci & Naike Casagrande. (2018) Inhibition of the CCL5/CCR5 Axis against the Progression of Gastric Cancer. International Journal of Molecular Sciences 19:5, pages 1477.
Crossref
Crossref
Weiguo Han, David A. Jackson, Stephan J. Matissek, Jason A. Misurelli, Matthew S. Neil, Brandon Sklavanitis, Nansalmaa Amarsaikhan & Sherine F. Elsawa. (2017) Novel Molecular Mechanism of Regulation of CD40 Ligand by the Transcription Factor GLI2. The Journal of Immunology 198:11, pages 4481-4489.
Crossref
Crossref
Antonino Carbone, Annunziata Gloghini, Arnaldo Caruso, Paolo De Paoli & Riccardo Dolcetti. (2017) The impact of EBV and HIV infection on the microenvironmental niche underlying Hodgkin lymphoma pathogenesis. International Journal of Cancer 140:6, pages 1233-1245.
Crossref
Crossref
Donatella Aldinucci, Marta Celegato & Naike Casagrande. (2016) Microenvironmental interactions in classical Hodgkin lymphoma and their role in promoting tumor growth, immune escape and drug resistance. Cancer Letters 380:1, pages 243-252.
Crossref
Crossref
Frederik Wein & Ralf Küppers. (2016) The role of T cells in the microenvironment of Hodgkin lymphoma. Journal of Leukocyte Biology 99:1, pages 45-50.
Crossref
Crossref
Joseph G. Taylor & John G. Gribben. (2015) Microenvironment abnormalities and lymphomagenesis: Immunological aspects. Seminars in Cancer Biology 34, pages 36-45.
Crossref
Crossref
Eri Matsuki & Anas Younes. (2015) Lymphomagenesis in Hodgkin lymphoma. Seminars in Cancer Biology 34, pages 14-21.
Crossref
Crossref
M Sadeghi, I Lahdou, H Oweira, V Daniel, P Terness, J Schmidt, K-H Weiss, T Longerich, P Schemmer, G Opelz & A Mehrabi. (2015) Serum levels of chemokines CCL4 and CCL5 in cirrhotic patients indicate the presence of hepatocellular carcinoma. British Journal of Cancer 113:5, pages 756-762.
Crossref
Crossref
Antonino Carbone & Anas YounesMaria Costanza Aquilano & Antonino Carbone. 2015. Hodgkin And Non-Hodgkin Lymphomas Seen Through Their Microenvironment: Impact on Diagnosis, Prognosis and Innovative Therapy (Volume 2). Hodgkin And Non-Hodgkin Lymphomas Seen Through Their Microenvironment: Impact on Diagnosis, Prognosis and Innovative Therapy (Volume 2)
2
19
.
Antonino Carbone & Anas Younes. 2015. Hodgkin And Non-Hodgkin Lymphomas Seen Through Their Microenvironment: Impact on Diagnosis, Prognosis and Innovative Therapy (Volume 2). Hodgkin And Non-Hodgkin Lymphomas Seen Through Their Microenvironment: Impact on Diagnosis, Prognosis and Innovative Therapy (Volume 2).
Tejas Suresh, Lisa X Lee, Jitesh Joshi & Stefan K Barta. (2014) New antibody approaches to lymphoma therapy. Journal of Hematology & Oncology 7:1.
Crossref
Crossref
Kung-Chao Chang, Yao Chang, Lily Hui-Ching Wang, Hung-Wen Tsai, Wenya Huang & Ih-Jen Su. (2014) Pathogenesis of virus-associated human cancers: Epstein–Barr virus and hepatitis B virus as two examples. Journal of the Formosan Medical Association 113:9, pages 581-590.
Crossref
Crossref
Marta Celegato, Cinzia Borghese, Kazuo Umezawa, Naike Casagrande, Alfonso Colombatti, Antonino Carbone & Donatella Aldinucci. (2014) The NF-κB inhibitor DHMEQ decreases survival factors, overcomes the protective activity of microenvironment and synergizes with chemotherapy agents in classical Hodgkin lymphoma. Cancer Letters 349:1, pages 26-34.
Crossref
Crossref
Catherine Diefenbach & Ranjana Advani. (2014) Customized Targeted Therapy in Hodgkin Lymphoma. Hematology/Oncology Clinics of North America 28:1, pages 105-122.
Crossref
Crossref
Donatella Aldinucci & Alfonso Colombatti. (2014) The Inflammatory Chemokine CCL5 and Cancer Progression. Mediators of Inflammation 2014, pages 1-12.
Crossref
Crossref
Michelle Fanale, Sarit Assouline, John Kuruvilla, Philippe Solal-Céligny, Dae S. Heo, Gregor Verhoef, Paolo Corradini, Jeremy S. Abramson, Fritz Offner, Andreas Engert, Martin J. S. Dyer, Daniel Carreon, Brett Ewald, Johan Baeck, Anas Younes & Arnold S. Freedman. (2014) Phase IA/II, multicentre, open-label study of the CD40 antagonistic monoclonal antibody lucatumumab in adult patients with advanced non-Hodgkin or Hodgkin lymphoma. British Journal of Haematology 164:2, pages 258-265.
Crossref
Crossref
Fathima Zumla Cader, Martina Vockerodt, Shikha Bose, Eszter Nagy, Marie-Anne Brundler, Pamela Kearns & Paul G. Murray. (2013) The EBV oncogene LMP1 protects lymphoma cells from cell death through the collagen-mediated activation of DDR1. Blood 122:26, pages 4237-4245.
Crossref
Crossref
Zhi-Qing Wang, Jun Wang, Wei-Hua Ling, Xue-Guang Zhang & Qin Shi. (2013) Effects of CD40 ligation combined with chemotherapy drugs on human breast cancer cell lines. Journal of International Medical Research 41:5, pages 1495-1504.
Crossref
Crossref
Luis de la Cruz-Merino, Marylène Lejeune, Esteban Nogales Fernández, Fernando Henao Carrasco, Ana Grueso López, Ana Illescas Vacas, Mariano Provencio Pulla, Cristina Callau & Tomás Álvaro. (2012) Role of Immune Escape Mechanisms in Hodgkin's Lymphoma Development and Progression: A Whole New World with Therapeutic Implications. Clinical and Developmental Immunology 2012, pages 1-24.
Crossref
Crossref